Indian J Radiol Imaging. 2009 Feb; 19(1): 43–48. doi: 10.4103/0971-3026.

45344

Intracranial dural arteriovenous fistulas: A Review

AK Gupta and AL Periakaruppan

Abstract
Dural arteriovenous fistulas are fistulas connecting the branches of dural arteries to dural veins
or a venous sinus. Digital subtraction angiography remains the gold standard for diagnosing
these fistulas. Endovascular treatment is one of the first line options available for their
management. This review article reviews the etiopathogenesis, natural history, common
classification systems and various available treatment options.
Keywords: Coil embolisation, dural arteriovenous fistula

Introduction
Yasargill noted that Rizzoli, in 1881, was the first to describe an arteriovenous malformation
(AVM) that involved the dura mater and Sachs reported the first, angiographic description in
1931. Subsequently cranial dural fistulas have been most frequently described at the transverse
sinus and cavernous sinus, although they occur at every cranial dural sinus. Dural arteriovenous
fistulas (DAVFs) can occur anywhere within the intracranial dura mater. DAVFs are rare
vascular abnormalities. They consist of numerous tiny connections between branches of dural
arteries and veins or a venous sinus.[1] The true incidence of DAVFs is unknown.[2] However,
the reported incidence of intracranial DAVFs is approximately 10-15% of all intracranial
vascular abnormalities. A good percentage of DAVFs remain clinically silent or involute
spontaneously and therefore the true incidence may be much more.[3] Present evidence
suggests that DAVFs are acquired lesions and present later in life than AVMs.[4]

Etiopathology
Before the mid-1970s DAVFs were thought to be congenital in origin and to be associated with
other vascular lesions. In the late 1970s, Castaigne and Djindjian proposed an acquired
etiology. They suggested that DAVFs may develop due to the opening up of existing micro
shunts within the dura and by angioneogenesis, leading to the development of new shunts.
Various etiologies are postulated: e.g., anomalies of venous system, venous thrombosis, head
trauma, transcranial surgery, association with pregnancy, delivery and menopause, increased
systemic thrombotic activity, cortical vein thrombosis (CVT), role of hormonal changes (use
of oral contraceptive and pregnancy) causing increased angiogenesis, tumors (meningiomas
obstruct dural venous outflow), general surgery, otitis, and sinusitis.[5]
Understanding of the pathophysiology of DAVFs came from the school of La Salpetriere,
which emphasized the role of the cortical venous drainage of these dural shunts.[5] Henceforth,
the role of the subarachnoid and subpial venous drainage could be correlated with the type of
neurological manifestation and the natural history of dural shunts. Conditions associated with
DAVFs include stenosis or occlusion of the draining dural sinuses, sinus thrombosis,
prothrombin gene mutation, resistance to activated protein (APCR), mutation in factor V gene,
and presence of antiphospholipid antibodies.
DAVFs in adulthood are an acquired disease and there is no relationship to hereditary or
developmental disorders. On the other hand, we have seen brain AVMs as well as cavernomas
occur in patients with DAVFs. Vascular diseases associated with dural arteriovenous shunts
include cerebral AVM, maxillofacial AVM, hereditary hemorrhagic telangiectasia, bone
AVM, cavernomas, and intradural or extradural arterial aneurysms.[5] Multiple DAVFs at
separate locations in the same patient have also been reported.[5,6]
The common predisposing factor for DAVFs appears to be venous sinus thrombosis.[7] The
venous hypertension developing after venous thrombosis opens up the microvascular
connections within the dura.[8] Without intervention, these channels become hypertrophied
resulting in direct shunting between the arteries and veins [Table 1].[7] When the fistula grows
and becomes more diffuse, it recruits pial supply from parenchymal vessels. This may lead to
the angiomatous network of multiple feeding arteries and numerous AV shunts within a
partially recanalized sinus that is frequently seen at angiography. The involved dural sinus
receives arterialized blood flow that can lead to mechanical obstruction of the sinus and result
in retrograde drainage of blood away from the sinus and into the cortical veins.
Histopathological analysis of excised DAVFs has revealed thrombosis and angiographic
progression of sinus thrombosis to DAVF. In addition, dilatation of the cortical veins may
occur, predisposing the patient to intracranial hemorrhage.
Table 1
Classification of dural arteriovenous fistulas
Borden classification
1 Venous drainage directly into dural venous sinus or meningeal vein
2 Venous drainage into dural venous sinus with CVR
3 Venous drainage directly into subarachnoid veins (CVR only)

Cognard et al.
I Venous drainage into dural venous sinus with antegrade flow
II a Venous drainage into dural venous sinus with retrograde flow
II b Venous drainage into dural venous sinus with antegrade flow and CVR
II a + b Venous drainage into dural venous sinus with retrograde flow and CVR
III Venous drainage directly into subarachnoid veins (CVR only)
IV Type III with venous ectasias of the draining subarachnoid veins
V Direct drainage into spinal perimedullary veins
(CVR indicates cortical venous reflux)
Another mechanism for DAVF evolution is the release of angiogenic growth factors such as
vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF), which
promotes neovascularization and development of a DAVF [Tables 2 and 3]. These factors by
themselves should therefore not be considered as the direct cause of DAVFs, but rather they
make up an environment that may be conducive to the development of DAVF, depending on
the individual host response to their presence. DAVF in adults are triggered by factors that
stimulate angiogenesis. If this angiogenic process is simultaneously associated with loss of
some of the venular surface properties, then venous thrombosis is likely to occur. It has been
noted that angiogenic growth factors such as basic fibroblast growth factor (bFGF) and vascular
endothelial growth factor (VEGF) are expressed in the DAVFs. In DAVFs with a patent sinus,
cortical venous pathways usually do not develop and hemorrhagic complications with these
DAVFs are infrequent.[9]

Osteodural-venous complex
At birth, the total cerebral venous drainage is directed towards the posterior sinuses, i.e. a true
sinusal system.[5] Few months after birth that the so-called cavernous capture of sylvian vein
will occur and offer the infant brain an alternate drainage via the cavernous plexus toward the
orbit or the pterygoid plexus and into the external jugular venous system. The dura mater along
the convexity of the cranial vault has a different origin from the dural along the base of the
skull (membranous vs. cartilaginous bone). Septations may occur within the dural sinuses and
result in separate venous channels, one of these channels may be used for the brain to drain
while the other is sometimes exclusively used for the drainage of the DAVF and may be the
specific target for treatment.[10] A peculiar group of lesions are the intracranial arteriovenous
shunts fed by the dural arteries (that also supply the bone), which are located with in the bony
structures along the convexity or at the base of the skull: the so called osteodural AVFs.
The incidence of DAVF at various locations as reported in literature is as follows: transverse
sinus 50%, cavernous sinus 16%, tentorium cerebelli 12%, and superior sagittal sinus, 8%.[6]

Natural history
The natural history of DAVFs is poorly documented and mostly reviewed retrospectively.
Davis et al, followed 102 patients with intracranial DAVFs for an average of 33 months, with
complete follow up in 91%. In his series, 55 patients had DAVFs without leptomeningeal and
cortical venous reflux and, of these, 32 received no treatment. Among the patients who received
no treatment, 81% had symptom improvement or complete resolution as compared to 86% of
the treated patients with the same angioarchitecture. In the same series, there were 46 patients
who had DAVFs with leptomeningeal or cortical venous reflux and 14 of these declined further
treatment. At follow-up, this group had an 11% nonhemorrhagic neurological deficit rate per
year and a 20% intracerebral hemorrhage (ICH) rate per year.[5] In an updated review of 118
patients with DAVFs and leptomeningeal reflux, the Toronto team demonstrated an annual risk
for nonhemorrhagic neurological deficit of 6.9% and a risk of 8.1% for hemorrhage, with an
annual mortality rate of 10.4%.[5]
Many DAVFs remain stable and do not change on follow-up. Some involute spontaneously;
this may be due to thrombosis following DSA. Some DAVFs undergo progressive recruitment
of pachymeningeal feeders with the worsening of symptoms. The actual progress of lesions
once symptoms develop is unknown. By location, an aggressive course is seen in 75% of
anterior fossa lesions, 79% of tentorial lesions, 60% of foramen magnum lesions, and 29% of
transverse sinus lesions.[5] Factors predisposing to an aggressive course include
leptomeningeal (cortical) venous drainage, galenic drainage (deep veins), variceal or
aneurysmal venous dilatations, and location at the tentorial incisura. This incidence parallels
that of the leptomeningeal retrograde venous drainage at each of these locations. The reported
annual morbidity and mortality rates of aggressively presenting DAVFs may vary widely,
ranging from 1.8-20% per year.[11]

Clinical presentation
Patients with DAVFs may be completely asymptomatic. Symptoms, when present, may range
from mild symptoms to fatal hemorrhage. The symptoms depend on the location and venous
and drainage pattern of the DAVF. The clinical symptoms of the majority of DAVFs involving
the superior sagittal, lateral, sigmoid and straight sinuses are often related to the route of venous
drainage.[8] A petrous region DAVF draining into the transverse or sigmoid sinus commonly
produces pulsatile tinnitus, with or without an associated bruit. Such patients may be managed
conservatively, depending upon the pattern of venous drainage. Bruit and headache are
common symptoms in DAVFs and are usually unrelated to cortical venous drainage. Carotid
cavernous DAVFs often present with the classic clinical findings of proptosis, chemosis, and
bruit. Treatment of a carotid cavernous DAVF is usually undertaken to protect against ocular
and visual complications.
Symptoms of DAVFs may be characterized further as either nonaggressive (e.g., tinnitus) or
aggressive (e.g., intracerebral, subarachnoid, or subdural hemorrhage and neurologic
deficits).[5,10] These aggressive features are usually due to venous hypertension, although
neurological deficits may be secondary to arterial steal.[6] A DAVF demonstrating venous
occlusive disease is at a higher risk for complications from the arterialized collateral venous
system. Aggressive neurological symptoms are more common in male patients who have
aggressive angiographic features like retrograde leptomeningeal venous drainage, variceal or
aneurysmal venous structures, and galenic venous drainage.[12] Earlier treatment of DAVFs
that have these features is important to prevent complications. The risk of conversion from a
benign to an aggressive DAVF is small but repeat angiography is indicated if the clinical
picture appears to progress.[13]

Classification system
The initial classification of DAVFs proposed in 1978 by Djindjian and Merland was based on
venous drainage;[14] it was recently modified by Cognard et al,[15] Table 1 shows two
commonly used classification systems. The Borden classification has three subtypes and is
more user-friendly.[4] The Cognard system is based on venous drainage. It provides more
detailed and elaborate information on the presence of normal or abnormal venous drainage and
presence or absence of cortical venous recruitment and also takes into account the spinal
perimedullary venous drainage.[10] Thus, it enables accurate comparison of clinical and
radiological parameters.

Imaging
Imaging by CT, CT angiography (CTA), MRI, and angiography play an important role in the
investigation of patients with DAVFs. Due to varying nonspecific clinical and imaging features
the diagnosis of a DAVF can be delayed or missed. Occasionally a plain film may be useful as
it can show grooving within the skull vault due to chronic venous hypertension and
compression by middle meningeal vessels.
Before any intervention, a nonenhanced CT must be done to rule out intracranial hemorrhage.
Chronic venous congestion produces an area of low density on CT due to edema. Multidetector
CTA, because of its rapid acquisition, can now provide high-resolution detail of vascular
anatomy and has a temporal advantage over static CT. DAVFs can present as tinnitus and CT
scan may help in detecting ear abnormalities such as aberrant vascular anatomy or glomus
tumors. Linear bony defects formed by enlarged emissary veins can indicate the presence of a
fistula.[16] MRI in DAVFs shows dilated cortical veins without a parenchymal nidus. It can
also provide clues about DAVF in the presence of veno-occlusive disease. Other MRI imaging
appearances include thickened dural leaflet; hypertrophied pachymeningeal arteries; dilated,
tortuous, and variceal venous channels; and a thrombosed or stenosed dural venous sinus. The
arterial supply to the DAVF is not demonstrated on MR images.
PET-based regional cerebral blood flow (rCBF) studies indicate that decreased rCBF may be
important in the pathogenesis of the neurological symptoms. In patients with normal cortical
venous drainage, values for rCBF, regional cerebral metabolic rate of oxygen (rCMRO), and
regional oxygen extraction fraction (rOEF) were normal. Reduced rCBF and mildly or
markedly increased rOEF is seen in patients with clinical symptoms and cortical venous
drainage.[11]

Angiography
Angiography remains the gold standard for diagnosis and planning of therapy. In addition to
diagnosis, anatomical and hemodynamic assessment of the fistula needs to be performed. The
aim is not only to identify the arterial feeders and the site of the fistula but also to identify the
pattern and direction of venous drainage of the fistula and normal cerebral parenchyma.
Selective injection of all potential arteries that may contribute to the region of dural pathology
needs to be done. The acquisition of images should begin in the early arterial phase and
continue into the late venous phase of the study. A dual arterial injection (competitive
angiogram) may be required to study the venous drainage of fistula and normal brain. In this
technique first selective injection is done in ICA followed by ECA. Then by using resubtraction
and changing of the mask runs, drainage of the fistula and normal brain parenchyma can be
superimposed. The angiogram should be analyzed for feeders, type of venous drainage,
retrograde flow, occlusion of sinuses, and circulation time. The angiogram should be analyzed
for feeders, type of venous drainage, retrograde flow, occlusion of sinuses, and circulation time.
The common angiographic findings seen are feeders from pial and dural branches, AV
shunting, venous ectasia, stenosis, calcifications, impaired drainage of cerebral parenchyma
with delayed venous drainage, and cortical venous collaterals.

Cortical rerouting
Aggressive symptoms are shown by those DAVFs, which drain retrogradely by leptomeningeal
cortical venous channels. Awad et al, pointed out the aggressive factors as leptomeningeal
cortical venous drainage, galenic deep venous drainage, variceal or aneurismal dilatations and
lesions located at the tentorial incisura.[12] Houser et al,[8] point out that the sinus need not
even be thrombosed to cause retrograde venous drainage into cortical veins. Partial filling of
sinuses by the high-pressure arterial blood can impede antegrade venous drainage. A high
frequency of hemorrhage is reported in DAVFs involving the anterior cranial fossa and
tentorium. These DAVFs almost always drain into intradural veins.[17] Apart from
hemorrhage, retrograde venous flow accompanied by increased venous pressure can lead to
chronic passive congestion and venous infarcts, which are a major cause of focal neurologic
deficits in DAVFs. Hydrocephalus is another complication of DAVF. It is due to decreased
absorption of cerebrospinal fluid due to increased venous pressure or mechanical compression
of the aqueduct by mesencephalic veins.

Treatment
General treatment approaches for the treatment of DAVFs include the following:
1. Conservative treatment
2. Neuroradiological endovascular intervention, which comprises of:
i. Particulate embolization
ii. Glue or onyx injection through arterial or venous route
iii. Coiling with or without glue or onyx injection [Figures [Figures11–3]
Figure 1: (A-F)
DAVF Type 1: Postcontrast coronal T1W MRI image (A) shows multiple
tortuous flow voids (arrow) adjacent to the right sigmoid sinus. Selective right
external carotid artery (ECA) (B) and internal carotid artery (ICA) (lateral view)
(C) angiograms shows a DAVF type 1 with feeders (arrow) from the posterior
meningeal branch of the middle meningeal artery and dural branches (arrow)
from the cavernous ICA draining antegradely through the sigmoid sinus.
Posttreatment selective right ECA (lateral view) (D) and ICA (anteroposterior
view; arterial (E) and venous (F) phases) angiograms show coils (arrows)
packing the right distal transverse and sigmoid sinus with total obliteration of
the fistula
 Figure 3: (A-F)
DAVF Type 2b: Selective right ICA (A), ECA (B) and vertebral artery (VA)
(lateral view) (C) angiograms show DAVF type 2 b, with feeders from dural
branches (arrow) of the ICA, posterior meningeal branch of the middle
meningeal artery (arrow) and dural branches (arrow) from the V3 segment of
the vertebral artery, draining antegradely through the straight sinus with venous
reflux. Post-treatment selective right ICA (D), ECA (E), and VA (lateral view)
(F) angiograms show coils (arrows) packing the vein of Galen and the straight
sinus, with near-total obliteration of the fistula and cortical venous reflux
iv. Venous stenting
3. Radiation therapy
4. Surgery
5. Combination of above, i.e., RT + intervention or intervention + surgery

Figure 2: (A-F)
DAVF Type 2 a + b: Selective right ICA (A, B) and ECA (lateral view) (C) angiograms show
a DAVF type 2 a + b, with feeders from the dural branches (arrow) of the ICA and the posterior
meningeal branch of the middle meningeal artery (arrow) draining retrogradely through the
transverse sinus. Post-treatment selective right ECA (lateral view) (D) and ICA (lateral view,
arterial phase (E); anteroposterior view, venous phase (F)) angiograms show coils (arrows)
packing the right distal transverse and sigmoid sinus with total obliteration of the fistula
1. Conservative treatment
Conservative treatment involves mainly symptomatic treatment and supportive measures.
Spontaneous regression of dural DAVFs has been reported.[18]
2. Endovascular neuroradiological intervention
Transarterial route
i. Particulate embolization: Embolization of external carotid branches with particles is
easily performed and can reduce shunt flow. Transarterial particulate embolization
typically is not curative. Total obliteration is difficult to achieve with this method
because some feeding arteries cannot be catheterized and because of the recruitment of
blood supply from collateral arteries.[19] Therefore, it is generally used to relieve
symptoms or in combination with other procedures such as irradiation, surgery, or
transvenous embolization (TVE).
ii. N-butyl-2-cyanoacrylate or onyx embolization: Deposition of glue into the collecting
vein or fistula through the transarterial route may also result in cure, but it is less
controllable than coil embolization and thus may present a higher risk. Transarterial
embolization (TAE) with N-butyl-2-cyanoacrylate is regularly used to treat complex
DAVFs if percutaneous transvenous catheterization is not possible.[20] Onyx is a new
nonadhesive liquid embolic agent. It is supplied in ready-to-use vials and is a mixture
of EVOH, DMSO, and tantalum. Onyx, after coming in contact with blood, gets
precipitated and occludes the vessels but is nonadherent to the vessel wall. This non-
adhesive property of onyx eliminates the risk of gluing of the microcatheter to the
vessels. This also allows a slow and prolonged single injection of the embolic agent
with concomitant check angiograms. Good positioning of the microcatheter and slow
injection can completely fill the fistula and enable a complete cure.
Currently onyx is available in two concentrations (FDA-approved) in the United States
for presurgical cerebral AVM embolization.[21] Depending on the need, onyx or glue
in mild to moderate concentration (20, 25, or 33%) may be injected.
iii. Coiling via transvenous route: Coils are now regularly used for curative purposes.
Many studies have reported their usefulness. Complete occlusion may occur in 80-
100% of cases.[22] An angiographically nonvisualized inferior petrosal sinus (IPS) can
be successfully catheterized in 30-50% of patients.[9] When this is thrombosed, the
transvenous access may be tried out via the superior petrosal sinus (SPS) facial vein,
angular vein, pterygoid sinus, and superior ophthalmic vein (SOV)[23] Inadequate
embolization leads to a worsening of symptoms.
 The use of detachable coils before onyx or glue injection slows and decreases flow in
the fistula and provides secure anchoring to the onyx or glue cast.
iv. Stent placement: Some authors have tried to close the shunts in the dural arteriovenous
fistulas with the help of stents.[24] Kieran et al, have postulated that it is possible to
recanalize a chronically occluded dural venous sinus and complete closure of multiple
DAVF feeders can be achieved by the deployment of stents.[25] Long-term results from
the use of stents in the treatment of DAVFs are not yet known. Antegrade sinus flow
can be established with the help of the radial force in the stent, which can close the
shunts in the sinus wall.[24]
3. Radiation therapy
Good results have been reported from the use of stereotactic radiotherapy for the treatment of
DAVFs, with complete occlusion being reported in 44-87% of cases.[26,27] This method,
although reported to be effective in several case reports or small series, carries an unacceptable
delay of 1–3 years in the cure of DAVFs with cortical venous reflux (CVR) and therefore is
not recommended as a primary therapeutic measure for these lesions.[28] The advantages of
radiotherapy include decreased invasiveness of the procedure and fewer short-term
complications; the major disadvantage is the latency of 6–12 months after irradiation before
there are tangible benefits. The combined use of stereotactic radiotherapy and TAE with
particles is in practice and it enhances the effectiveness of both the techniques. Combined
treatment gives good results and reduces the risk of worsening symptoms during the follow-up
period.[29,30]
4. Surgery
Endovascular management has become a first-line treatment for dural DAVFs. However, some
DAVFs of the anterior cranial fossa can often be treated more easily and safely with surgical
disconnection of the venous drainage.[29] Combination with endovascular procedures is
required in difficult cases where sinus isolation and resection are needed.

Conclusions
DAVFs with retrograde leptomeningeal venous drainage carry a high risk for neurological
sequelae or death, both at presentation and in the natural course of disease progression. With
presently available treatment modalities most of these lesions are either curable or, at the very
least, patients may get significant clinical improvement. The natural history of the condition
suggests that these lesions are aggressive and need prompt diagnosis and treatment.
Go to:
Footnotes
Source of Support: Nil
Conflict of Interest: None declared.
Go to:
References
1. Halbach VV, Higashida RT, Hieshima GB, Mehninger CM, Hardin CW. Transvenous
embolization of dural fistulas involving the transverse and sigmoid sinuses. AJNR Am J
Neuroradiol. 1989;10:385–92. [PubMed]
2. Newton TH, Cronqvist S. Involvement of dural arteries in intracranial arteriovenous
malformations. Radiology. 1969;93:1071–8. [PubMed]
3. Luciani A, Houdart E, Mounayer C, Saint Maurice JP, Merland JJ. Spontaneous closure of
dural arteriovenous fistulas: Report of three cases and review of the literature. AJNR Am J
Neuroradiol. 2001;22:992–6. [PubMed]
4. Borden JA, Wu JK, Shucart WA. A proposed classification for spinal and cranial dural
arteriovenous fistulous malformations and implications for treatment. J Neurosurg.
1995;82:166–79. [PubMed]
5. Lasjaunias P, Berenstein A. Dural arteriovenous shunts. Vol 2.2. Germany: Springer-Verlag;
2004. Surgical neuroangiography; pp. 565–607.
6. Lasjaunias P, Chiu M, TerBrugge K, Tolia A, Hurth M, Bernstein M. Neurological
manifestations of intracranial dural arteriovenous malformations. J Neurosurg. 1986;64:724–
30. [PubMed]
7. Kwon BJ, Han MH, Kang HS, Chang KH. MR imaging features of intracranial dural
arteriovenous fistulas: Relations with venous drainage patterns. AJNR Am J Neuroradiol.
2005;26:2500–7. [PubMed]
8. Houser O, Campbell J, Campbell R, Sundt I. Arteriovenous malformation affecting the
transverse dural venous sinus: An acquired lesion. Mayo Clin Proc. 1979;54:651–61.
[PubMed]
9. Fox AJ, Pelz DM, Drake CG. Unusual clinical manifestations of dural arteriovenous
malformations. J Neurosurg. 1986;64:554–8. [PubMed]
10. Cognard C, Gobin YP, Pierot L, Bailly AL, Houdart E, Casasco A, et al. Cerebral dural
arteriovenous fistulas: Clinical and angiographic correlation with a revised classification of
venous drainage. Radiology. 1995;194:671–80. [PubMed]
11. Iwama T, Hashimoto N, Takagi Y, Tanaka M, Yamamoto S, Nishi S, et al. Haemodynamic
and metabolic disturbances in patients with intracranial dural arteriovenous fistulas: Positron
emission tomography evaluation before and after treatment. J Neurosurg. 1997;86:806–11.
[PubMed]
12. Awad IA, Little RJ, Akarawi WP, Ahl J. Intracranial dural arteriovenous malformations:
factors predisposing to an aggressive neurological course. J Neurosurg. 1990;72:839–50.
[PubMed]
13. Satomi J, van Dijk JM, Terbrugge K, Willinsky RA, Wallace MC. Benign cranial dural
arteriovenous fistulas: Outcome of conservative management based on the natural history of
the lesion. J Neurosurg. 2002;97:767–70. [PubMed]
14. Djindjian R, Merland JJ. New York: Springer-Verlag; 1977. Superselective angiography
of external carotid artery; pp. 606–28.
15. Cognard C, Casaco A, Toevi M, Houdart Chiras J, Merland JJ. Dural arteriovenous fistulas
as a cause of intracranial hypertension due to impairment of cranial venous outflow. J Neurol
Neurosurg Psychiatry. 1998;65:308–16. [PMC free article] [PubMed]
16. Alatakis S, Koulouris G, Stuckey S. CT-Demonstrated transcalvarial channels diagnostic
of dural arteriovenous fistula. AJNR Am J Neuroradiol. 2005;26:2393–6. [PubMed]
17. Ito J, Imamura H, Kobayashi K, Tsuchida T, Sato S. Dural arteriovenous malformations of
the base of the anterior cranial fossa. Neuroradiology. 1983;24:149–54. [PubMed]
18. Barrow DL, Spector RH, Braun IF, Landman JA, Tindall SC, Tindall GT. Classification
and treatment of spontaneous carotid cavernous sinus fistulas. J Neurosurg. 1985;62:248–56.
[PubMed]
19. Kawaguchi S, Sakaki T, Morimoto T, Hoshida T, Nakase H. Surgery for dural
arteriovenous fistula in superior sagittal sinus and transverse sinus. J Clin Neurosci. 2000;7:47–
9. [PubMed]
20. Tomak PR, Cloft HJ, Kaga A, Cawley CM, Dion J, Barrow DL. Evolution of the
management of tentorial dural arteriovenous malformations. Neurosurgery. 2003;52:750–62.
[PubMed]
21. Troffkin NA, Graham CB, 3rd, Berkmen T, Wakhloo AK. Combined transvenous and
transarterial embolization of a tentorial-incisural dural arteriovenous malformation followed
by primary stent placement in the associated stenotic straight sinus: Case report. J Neurosurg.
2003;99:579–83. [PubMed]
22. Quinones D, Duckwiler G, Gobin PY, Goldberg RA, Viñuela F. Embolization of dural
cavernous fistulas via superior ophthalmic vein approach. AJNR Am J Neuroradiol.
1997;18:921–8. [PubMed]
23. Suzuki S, Lee DW, Jahan R, Duckwiler GR, Viñuela F. Vinuela technical note transvenous
treatment of spontaneous dural carotid-cavernous fistulas using a combination of detachable
coils and onyx. AJNR Am J Neuroradiol. 2006;27:1346–9. [PubMed]
24. Murphy KJ, Gailloud P, Venbrux A, Deramond H, Hanley D, Rigamonti D. Endovascular
treatment of grade IV transverse sinus dural arteriovenous fistula by sinus recanalization,
angioplasty, and stent placement: Technical case report. Neurosurgery. 2000;46:497–501.
[PubMed]
25. O'Leary S, Hodgson TJ, Coley SC, Kemeny AA, Radatz MW. Intracranial dural
arteriovenous malformations: Results of stereotactic radiosurgery in 17 patients. Clin Oncol (R
Coll Radiol) 2002;14:97–102. [PubMed]
26. Guo WY, Pan DH, Wu HM, Chung WY, Shiau CY, Wang LW, et al. Radiosurgery as a
treatment alternative for dural arteriovenous fistulas of the cavernous sinus. AJNR Am J
Neuroradiol. 1998;19:1081–7. [PubMed]
27. Bertalanffy A, Dietrich W, Kitz K, Bavinzski G. Treatment of dural arteriovenous fistulae
(dAVF's) at the superior sagittal sinus (SSS) using embolisation combined with micro- or
radiosurgery. Minim Invasive Neurosurg. 2001;44:205–10. [PubMed]
28. Lewis AI, Tomsick TA, Tew JM., Jr Management of tentorial dural arteriovenous
malformations: Transarterial embolization combined with stereotactic radiation or surgery. J
Neurosurg. 1994;81:851–9. [PubMed]
29. Lawton MT, Chun J, Wilson CB, Halbach VV. Ethmoidal dural arteriovenous fistulae: An
assessment of surgical and endovascular management. Neurosurgery. 1999;45:805–11.
[PubMed]
30. Friedman JA, Pollock BE, Nichols DA, Gorman DA, Foote RL, Stafford SL. Results of
combined stereotactic radiosurgery and transarterial embolization for dural arteriovenous
fistulas of the transverse and sigmoid sinuses. J Neurosurg. 2001;94:886–91. [PubMed]